Friday June 23rd 2017

Archive for March, 2017

​Biogen wins another big Tecfidera patent case

​Biogen wins another big Tecfidera patent case

For the second time in as many weeks, Biogen has prevailed in a high-stakes legal dispute over patents on its blockbuster multiple sclerosis treatment Tecfidera. The U.S. Patent Trial and Appeal Board on Friday rejected a bid by Danish biotech Forward Pharma (Nasdaq: FWP) [Read More]

U.S. judge invalidates Acorda multiple sclerosis drug patents

U.S. judge invalidates Acorda multiple sclerosis drug patents

(Reuters) - A federal judge in Delaware on Friday struck down key patents held by Acorda Therapeutics Inc related to its multiple sclerosis drug Ampyra, causing the stock to tumble 24 percent before trading was halted. (Source: Reuters: Health) [Read More]

Immuno-fluorescence in 3-D

Immuno-fluorescence in 3-D

Potent Markers! We are seeing more3-D Cell Based Assays being used for Neuroscience Research. It is important researchers have theNeuron-Astroglial-Progenitor Markers required for staining in 3-D. This helps researchers determine the cell types present in their assays.I [Read More]

 Page 1 of 37  1  2  3  4  5 » ...  Last » 

Latest Topics

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Type I interferons could have role in natural improvement of RA during pregnancy

Type I interferons could have role in natural improvement of RA during pregnancy

An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children's Hospital [Read More]

Shared decision-making essential to optimal treatment and quality of life for patients with MS

Shared decision-making essential to optimal treatment and quality of life for patients with MS

One of the cornerstones of multiple sclerosis treatment is shared decision-making between patients and their doctors [Read More]

UC consortium formed to speed up development of new drugs

UC consortium formed to speed up development of new drugs

For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the [Read More]